[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
Sept 25, 1967

Direct Serum Bilirubin and the Sulfobromophthalein Test in Occult Liver Disease

Author Affiliations

From the Department of Pathology, Englewood (NJ) Hospital.

JAMA. 1967;201(13):1047-1049. doi:10.1001/jama.1967.03130130073022
Abstract

When a sensitive method for measuring direct serum bilirubin (DB) was used, a third of the patients with liver or biliary tract disease had elevated DB levels, but normal levels of total serum bilirubin (TB). The correlation of DB and sulfobromophthalein (BSP) retention was studied because DB and BSP are cleared through the same hepatic pathway. Our findings support the clinical and chemical validity of DB measurements as an index of occult liver disease.

References
1.
Watson, C.J.:  The Importance of the Fractional Serum Bilirubin Determination in Clinical Medicine ,  Ann Intern Med 45:351-368 ( (Sept) ) 1956.Crossref
2.
Nosslin, B.:  The Direct Diazo Reaction of Bile Pigments in Serum: Experimental and Clinical Studies ,  Scand J Clin Lab Invest 12 ( (suppl 49) ): 1-176, 1960.Crossref
3.
Goresky, C.A.:  The Hepatic Uptake and Excretion of Sulfobromophthalein and Bilirubin ,  Canad Med Assoc J 92:851-857 ( (April 17) ) 1965.
4.
Malloy, H.T., and Evelyn, K.A.:  The Determination of Bilirubin With the Photoelectric Colorimeter ,  J Biol Chem 119:481-490 ( (July) ) 1937.
5.
Weber, A.P., and Schalm, L.:  Quantitative Separation and Determination of Bilirubin and Conjugated Bilirubin in Human Serum ,  Clin Chim Acta 7:805-810 ( (Nov) ) 1962.Crossref
6.
Gambino, S.R.:  Six Key Laboratory Tests For Detecting Occult Liver Disease ,  Texas J Med 61:554-557 ( (July) ) 1965.
×